Monday, 11 September 2017

AbbVie reports two patient deaths in rheumatoid arthritis study

(Reuters) - AbbVie Inc said on Monday two patients died in a late-stage trial testing its drug to treat patients with moderate to severe rheumatoid arthritis.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)